1. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994. 118:766–780.
2. Ellenberger C Jr. Ischemic optic neuropathy as a possible early complication of vascular hypertension. Am J Ophthalmol. 1979. 88:1045–1051.
3. Tomsak RL, Remler BF. Anterior ischemic optic neuropathy and increased intraocular pressure. J Clin Neuroophthalmol. 1989. 9:116–118.
4. Beck RW, Savino PJ, Repka MX, et al. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology. 1984. 91:1334–1337.
5. Doro S, Lessell S. Cup-disc ratio and ischemic optic neuropathy. Arch Ophthalmol. 1985. 103:1143–1144.
6. Guyer DR, Miller NR, Auer CL, Fine SL. The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol. 1985. 103:1136–1142.
7. Ahn BC, Kim HS, Ahn HS. Clinical profile of the Optic neuritis in Korea. J Korean Ophthalmol Soc. 1997. 38:1827–1833.
8. Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991. 109:1673–1678.
9. Rizzo JF 3rd, Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology. 1988. 38:185–190.
10. Park WC, Chang BL. Clinical features of anterior ischemic optic neuropathy. J Korean Ophthalmol Soc. 2003. 44:144–149.
11. Rizzo JF 3rd, Lessell S. Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol. 1991. 109:1668–1672.
12. Arnold AC, Hepler RS. Natural history of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 1994. 14:66–69.
13. Beck RW, Cleary PA. Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol. 1993. 111:773–775.
14. Boghen DR, Glaser JS. Ischaemic optic neuropathy. The clinical profile and history. Brain. 1975. 98:689–708.
15. Jung JY, Kim JS. Comparison of optic disc appearance in anterior ischemic optic neuropathy and optic neuritis. J Korean Ophthalmol Soc. 2003. 44:157–161.
16. Ischemic Optic Neuropathy Decompression Trial Research Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996. 114:1366–1374.
17. Kim DH, Hwang JM. Risk factors for Korean patients with anterior ischemic optic neuropathy. J Korean Ophthalmol Soc. 2007. 48:1527–1531.
18. Hayreh SS. Anterior ischaemic optic neuropathy. II. Fundus on ophthalmoscopy and fluorescein angiography. Br J Ophthalmol. 1974. 58:964–980.
19. Hayreh SS. Anterior ischaemic optic neuropathy. Differentiation of arteritic from non-arteritic type and its management. Eye. 1990. 4(Pt 1):25–41.
20. Arnold AC, Hepler RS. Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994. 117:222–230.
21. Anmarkrud N. The value of fluorescein fundus angiography in evaluating optic disc oedema. Acta Ophthalmol (Copenh). 1977. 55:605–615.
22. Mack HG, O'Day J, Currie JN. Delayed choroidal perfusion in giant cell arteritis. J Clin Neuroophthalmol. 1991. 11:221–227.
23. Siatkowski RM, Gass JD, Glaser JS, et al. Fluorescein angiography in the diagnosis of giant cell arteritis. Am J Ophthalmol. 1993. 115:57–63.
24. Evans PY, Shimizu K, Limaye S, et al. Fluorescein cineangiography of the optic nerve head. Trans Am Acad Ophthalmol Otolaryngol. 1973. 77:OP260–OP273.
25. Schatz H. Ryan SJ, editor. Fluorescein angiography: basic principles and interpretation. Retina. 2006. v. 2:4th ed. St. Louis: Mosby;873–916. chap. 51.